88312441 - INHATARGET

Information

• Trademark
• 88312441

• Source

• Serial Number

  88312441

• Registration Number

  6005331

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  February 22, 2019
  5 years ago

• Registration Date

  March 10, 2020
  4 years ago

• Transaction Date

  December 08, 2022
  2 years ago

• Status Date

  March 10, 2020
  4 years ago

• Published for Opposition Date

  December 24, 2019
  5 years ago

• Location Date

  March 10, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EULIN, INGRID C

• Attorney Docket Number

  7289-314

  Attorney Name

  Clifford D. Hyra

  Law Office Assigned Location Code

  M20

• Owners

  • Universite Libre De Bruxelles

Case File Statements

• GS0051: Pharmaceutical and veterinary preparations for the treatment of respiratory diseases and disorders; Chemicals and chemical preparations for medical and veterinary use, all for administration to human or animal patients, namely, chemical reagents for medical or veterinary purposes; Pharmaceutical preparations for pulmonary administration, namely, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Preparations for inhalation, namely, inhaled pharmaceuticals for the treatment of respiratory diseases and disorders; Powders for inhalers, namely, pharmaceutical preparation of inhalation for the treatment of asthma; Powders for asthma inhalers, namely, powder preparation for the treatment of asthma; Powders for transdermal injection, namely, pharmaceutical preparation for use in treating respiratory diseases and disorders; Pharmaceutical and veterinary preparations for oral ingestion, namely, pharmaceutical preparation for the treatment of respiratory diseases and disorders through oral ingestion; Pharmaceuticals and veterinary preparations for local administration, medicated preparations for the treatment of respiratory diseases and disorders
• GS0011: Chemicals and chemical compositions for use in manufacturing medical preparations
• GS0101: Medical and veterinary apparatus, articles and aids, all for the administration of pharmaceutical preparations to human or animal patients, namely, medical instruments for use in treating respiratory diseases and disorders, surgical instruments and apparatus, and catheter for veterinary purposes; Pharmaceutical preparation administration aids, namely, medical apparatus for introducing pharmaceutical preparations into the human body; devices for applying medicine, namely, inhalators sold empty; Inhalers for medical purposes sold empty; Dry powder inhalers for medical purposes, sold empty; Inhalers for treating asthma, namely, nebulizer for administering medication in the form of a mist inhaled into the lungs, for treatment of asthma, parts and fittings for all the aforesaid goods
• GS0421: Scientific research and development with respect to pharmaceutical preparations, apparatus and aids for administering medicines; design, development and laboratory testing of new pharmaceutical products, apparatus and aids for administering medicines; Medical and pharmaceutical research services; research in the field of medical administration apparatus and aids; Research in relation to medicine formulation, namely, research and development of vaccines and medicines; Research and development in the field of pharmaceuticals; product safety testing with respect to medical and pharmaceutical administration apparatus and aids; testing of pharmaceuticals

Case File Event Statements

• 12/8/2022 - 2 years ago

  27 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/8/2022 - 2 years ago

  26 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 12/8/2022 - 2 years ago

  25 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 3/10/2020 - 4 years ago

  24 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/16/2020 - 4 years ago

  23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 1/6/2020 - 5 years ago

  22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 12/24/2019 - 5 years ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/24/2019 - 5 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/4/2019 - 5 years ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/15/2019 - 5 years ago

  18 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 11/8/2019 - 5 years ago

  17 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 11/4/2019 - 5 years ago

  16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/4/2019 - 5 years ago

  15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 11/4/2019 - 5 years ago

  14 - ASSIGNED TO LIE Type: ALIE

• 11/4/2019 - 5 years ago

  13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 11/4/2019 - 5 years ago

  12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 11/4/2019 - 5 years ago

  11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/31/2019 - 5 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/30/2019 - 5 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/30/2019 - 5 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/26/2019 - 5 years ago

  7 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 5/4/2019 - 5 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/4/2019 - 5 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/4/2019 - 5 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/3/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/14/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 2/26/2019 - 5 years ago

  1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP